Kellerhals Carrard advised Roland Bays in the sale of Medlight to Rakuten Medical

Kellerhals Carrard advised Roland Bays, founder and CEO of Medlight, in the sale of his company to Rakuten Medical.

Medlight produces and commercializes a large range of optical fiber based catheters for accurate illumination of tissue, used in new tumor treatments based on light energy.

Rakuten Medical is a global biotechnology company developing precision, cell-targeting investigational therapies on its IlluminoxTM platform, which, in preclinical studies, have shown to lead to rapid and selective cell killing and tumor necrosis.

The team 


The Kellerhals Carrard team was composed of Frédéric Rochat (pictured), Elena Burger and Shima Gennari.

As previously announced by, Lenz & Staehelin advised Rakuten Medical in the acquisition of Medlight